DBV Technologies (DBVT) Free Cash Flow (2020 - 2026)
DBV Technologies (DBVT) posted quarterly Free Cash Flow of -$53.0 million for Q2 2026, down 56.34% year-on-year from -$121.4 million in Q2 2025, and down 7.07% on a QoQ basis from -$49.5 million in Q1 2026.
DBV Technologies (DBVT) Free Cash Flow (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Free Cash Flow for 7 consecutive years, with -$53.0 million the latest figure, recorded in Q2 2026.
- Quarterly Free Cash Flow fell 56.34% year-over-year to -$53.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$170.6 million (down 92.61% YoY) and the FY2025 annual result came in at -$121.7 million, down 13.95% from the prior year.
- Free Cash Flow retreated to -$53.0 million in Q2 2026 per DBVT's latest filing, from -$49.5 million in the prior quarter.
- Over the last five years, Free Cash Flow for DBVT reached as high as -$1.6 million in Q1 2022 and fell as low as -$53.0 million in Q2 2026.
- A 5-year average of -$26.0 million and a median of -$23.4 million in 2022 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow jumped 95.56% — and 2023, when it slumped 1198.14%.
- Year by year, Free Cash Flow stood at -$23.9 million in 2022, then surged by 41.26% to -$14.0 million in 2023, then advanced by 13.61% to -$12.1 million in 2024, then sank by 193.11% to -$35.5 million in 2025, then plunged by 49.1% to -$53.0 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$53.0 million, -$49.5 million, and -$35.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | -53.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -53.00 Mn |
| Jun 30, 2026 | -53.00 Mn |
| Mar 31, 2026 | -49.50 Mn |
| Mar 31, 2026 | -49.50 Mn |
| Dec 31, 2025 | -35.55 Mn |
| Dec 31, 2025 | -35.55 Mn |
| Sep 30, 2025 | -32.57 Mn |
| Sep 30, 2025 | -32.57 Mn |
| Jun 30, 2025 | -33.90 Mn |
| Jun 30, 2025 | -33.90 Mn |
| Mar 31, 2025 | -19.70 Mn |
| Mar 31, 2025 | -19.70 Mn |
| Dec 31, 2024 | -12.13 Mn |
| Dec 31, 2024 | -12.13 Mn |
| Sep 30, 2024 | -22.85 Mn |
| Sep 30, 2024 | -22.85 Mn |
| Jun 30, 2024 | -35.81 Mn |
| Jun 30, 2024 | -35.81 Mn |
| Mar 31, 2024 | -36.03 Mn |
| Mar 31, 2024 | -36.03 Mn |